Orion in the News
Orion Therapeutics, Inc. named a finalist for SXSW Pitch 2026 in the Healthcare, AssistiveTech & BioTech category
After receiving more than 600 applications, the SXSW Pitch Advisory Board carefully reviewed and scored each submission to identify the most promising companies. The finalists ...
Read More →
From Lab Bench to Breakthrough: How a UT Mentor-Student Partnership Sparked a Rising East Tennessee Biotech Company
When Trey Fisher, PhD, walked into the vascular biology lab led by Deidra Mountain, PhD, at the University of Tennessee Health Science Center College of Medicine ...
Read More →
Orion Therapeutics awarded NSF Phase II STTR grant to advance lead asset for restenosis, powered by our GENESYS™ targeted delivery platform
We are excited to announce that Orion Therapeutics has been awarded an NSF Phase II STTR grant to advance our lead asset for restenosis, powered ...
Read More →
Chiesi Global Rare Diseases and BioLabs announce Orion Therapeutics, Inc. as the winner of the recent US Network Golden Ticket
🎉 We’re thrilled to share some exciting news! 🎉Chiesi Global Rare Diseases and BioLabs are proud to announce Orion Therapeutics, Inc. as the winner of ...
Read More →
Volunteer 40 Under 40: Recognizing alumni under the age of 40 excelling personally and professionally since completing their degree at UT
Exciting News! Our CEO, Trey Fisher, PhD has been named a 2025 Volunteer 40 Under 40 Award recipient by the University of Tennessee, Knoxville!🎉 We’re ...
Read More →
Why a semi-retired baby boomer chose a passion project over a life of leisure: ‘There’s just an adrenaline rush’
For nearly a decade, Michael McCaman had an idea for a company — he just needed the right opportunity. Two years ago, when he was ...
Read More →
First recipient of Tennessee’s $5M startup fund has ‘limitless’ drug potential
"The University of Tennessee Research Foundation has selected Orion Therapeutics as the first recipient of its $5 million fund to support startups that bring research ...
Read More →
“InvestTN” announces seven new investments
"After making its first investment in November and 11 investments in the first quarter of 2024, Launch Tennessee has announced seven additional portfolio companies for the ...
Read More →
Nanotechnology-based Drug Delivery Platforms: 5 Startups to Watch!
"The growing use of nanotechnology in drug delivery is transforming healthcare by allowing for targeted, efficient, and controlled release of medications! These young companies are ...
Read More →
Orion Therapeutics Wins Golden Ticket Challenge for Lab Space at Biolabs Tufts Launch Pad
"Orion receives Golden Ticket for a year long occupancy in BioLabs supported by Chiesi. This represents a huge opportunity for Orion to extend its footprint ...
Read More →
Orion Therapeutics wins LSTCON “Venture Forum”
"Orion Therapeutics Inc., a Knoxville-based therapeutic company, won this year’s “Venture Forum” and a $10,000 cash prize from Holland & Knight that brought the curtain ...
Read More →
Orion Therapeutics Wins $100,000 in Genetic Medicine Grand Challenge
"Thrilled to Announce Orion Therapeutics as a Winner of the Eli Lilly and Company Genetic Medicine Grand Challenge! ... Orion Therapeutics has been named one ...
Read More →
Long-term vision and partnership: UTRF startup to develop next-generation RNA medicines using a novel drug delivery system
"Around a decade ago, a researcher at the University of Tennessee Graduate School of Medicine (UTSGM) and a graduate student in her lab began to ...
Read More →
MassBio’s Biotech Accelerator, MassBioDrive, Announces Fall 2022 Cohort of Startups
"The latest cohort of MassBioDrive, a key initiative of MassBio’s innovation programming designed to support entrepreneurs and startups, was announced today by MassBio and features ...
Read More →